Timing and Determinants of Postinjection Endophthalmitis after First-Time Anti-VEGF Administration
- 24 March 2026
- journal article
- Published by Elsevier in Ophthalmology Retina
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts Eye and Ear
This publication has 25 references indexed in Scilit:
- Smoking negatively impacts ocular surface health and corneal nerve metricsThe Ocular Surface, 2025
- Steroid-induced secondary immune deficiencyAnnals of Allergy, Asthma & Immunology, 2023
- Seasonal variation in acute post-cataract surgery endophthalmitis incidences in South KoreaJournal of Cataract & Refractive Surgery, 2019
- Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in FranceJAMA Ophthalmology, 2018
- Evolution of Intravitreal Therapy for Retinal Diseases—From CMV to CNV: The LXXIV Edward Jackson Memorial LectureAmerican Journal of Ophthalmology, 2018
- The Association between Intravitreal Steroids and Post-Injection Endophthalmitis RatesOphthalmology, 2015
- Association of Compounded Bevacizumab With Postinjection EndophthalmitisJAMA Ophthalmology, 2015
- Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual OutcomeAmerican Journal of Ophthalmology, 2015
- The Role of Topical Antibiotic Prophylaxis to Prevent Endophthalmitis after Intravitreal InjectionOphthalmology, 2014
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009